8-K: Cencora Repurchases $50 Million of Shares from Walgreens Boots Alliance
Share Repurchase Announcement
Cencora, Inc. has repurchased approximately $50 million of its common stock from Walgreens Boots Alliance Holdings LLC as part of a larger share sale by the latter.
Summary
- Cencora, Inc. entered into a share repurchase agreement with Walgreens Boots Alliance Holdings LLC on February 7, 2024.
- Cencora repurchased 212,395 shares of its common stock directly from Walgreens Boots Alliance.
- The repurchase price per share matched the price at which Walgreens Boots Alliance sold shares in a separate transaction.
- The total cost of the repurchase was approximately $50 million.
- The repurchased shares will be held in treasury.
- Walgreens Boots Alliance also sold 4,000,000 shares of Cencora stock under Rule 144 of the Securities Act of 1933.
- Following these transactions, Walgreens Boots Alliance owns approximately 13% of Cencora's outstanding shares, totaling 26,277,561 shares.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive as the share repurchase is a positive sign, but the reduction in Walgreens Boots Alliance's stake could be viewed with some caution.
Positives
- The share repurchase reduces the number of outstanding shares, potentially increasing earnings per share.
- The repurchase demonstrates Cencora's confidence in its financial position and future prospects.
- The company used cash on its balance sheet to complete the repurchase.
Negatives
- The share repurchase reduces Cencora's cash reserves by $50 million.
- Walgreens Boots Alliance reduced its stake in Cencora by selling 4,000,000 shares.
Risks
- The share repurchase agreement was contingent on the completion of the Rule 144 sale by Walgreens Boots Alliance.
- The agreement could have been terminated if the conditions were not met.
- The share repurchase may not have the desired effect on the stock price.
Future Outlook
The repurchased shares will be held in treasury, and the company will continue to evaluate its capital allocation strategy.
Management Comments
- The company intends to use cash on its balance sheet to complete the Repurchase.
Industry Context
Share repurchases are a common method for companies to return value to shareholders and can signal management's confidence in the company's future performance. This transaction is part of a larger trend of companies managing their capital structure and shareholder base.
Comparison to Industry Standards
- Share repurchases are a common practice among large publicly traded companies, especially those with strong cash flows.
- Companies like McKesson and Cardinal Health, which are Cencora's main competitors, also engage in share repurchase programs.
- The size of the repurchase, $50 million, is relatively small compared to the market capitalization of Cencora, but it is a meaningful transaction for the company.
Related Party Transactions
- The share repurchase agreement is a related party transaction between Cencora and Walgreens Boots Alliance Holdings LLC.
Stakeholder Impact
- Shareholders may view the share repurchase positively as it can increase earnings per share.
- The reduction in Walgreens Boots Alliance's stake could be a concern for some shareholders.
- The company's cash reserves are reduced by $50 million.
Next Steps
- Cencora will hold the repurchased shares in treasury.
- The company will continue to evaluate its capital allocation strategy.
Key Dates
| Date | Description |
|---|---|
| 2024-01-29 | Date used to calculate the total outstanding shares of Cencora prior to the repurchase. |
| 2024-02-07 | Date of the share repurchase agreement between Cencora and Walgreens Boots Alliance and the Rule 144 sale. |
| 2024-02-09 | Date the share repurchase was completed. |
Keywords
share repurchase, stock buyback, Walgreens Boots Alliance, Cencora, common stock, Rule 144, treasury shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.